机译:在预期期II试验中治疗的同步寡聚蛋白的NSCLC患者超过5年的无进展生存和整体存活率(NCT 01282450)
Department of Radiation Oncology (Maastro Clinic) GROW School for Oncology and Developmental;
Maastro Clinic;
Department of Pulmonology GROW School for Oncology and Developmental Biology Maastricht;
Maastro Clinic;
Maastro Clinic;
Maastro Clinic;
Department of Pulmonology Zuyderland Hospital;
Department of Pulmonology Laurentius Hospital;
Department of Pulmonology Sint Jans Gasthuis;
Department of Pulmonology GROW School for Oncology and Developmental Biology Maastricht;
Non-small cell lung cancer; oligometastases; long-term survival; phase II trial;
机译:在预期期II试验中治疗的同步寡聚蛋白的NSCLC患者超过5年的无进展生存和整体存活率(NCT 01282450)
机译:根治性非同步小转移肺癌非小细胞肺癌患者:一项前瞻性II期临床试验的长期结果(Nct01282450)
机译:以无进展生存期为终点的II期试验对间变性胶质瘤患者基于生存的III期研究的影响
机译:用于预测免疫疗法治疗的高级NSCLC患者存活的三角洲 - 辐射瘤
机译:统计模型捕获肿瘤学试验无进展和整体生存之间的关联
机译:以无进展生存期为终点的II期试验对间变性胶质瘤患者基于生存的III期研究的影响
机译:根治性治疗同步性寡转移的非小细胞肺癌患者的II期临床试验的长期结果(Nct01282450)